Dante's Update
Contains articles from Dante and our partners discussing the latest research, publications, and updates about genome sequencing.
Latest worldwide news
Share
Facebook
Twitter
LinkedIn
- SomaLogic, Inc. (NASDAQ:SLGC) Q2 2023 Earnings Call Transcript 17 August 2023 5:47 pm SomaLogic, Inc. (NASDAQ:SLGC) Q2 2023 Earnings Call Transcript August 14, 2023 SomaLogic, Inc. misses on earnings expectations. Reported EPS is $-0.13 EPS, expectations were $0.18. Operator: Good afternoon, and welcome to SomaLogic’s Second Quarter 2023 …
- SomaLogic Reports Second Quarter 2023 Financial Results 14 August 2023 8:05 pm Revenue of $20.5 million, an increase of 45% year-over-year Cash and investments of approximately $474 million, a strong capital position to fund current and future business initiatives Reiterating full year 2023 revenue guidance and operating expense …
- SomaLogic partnership brings proteomics tech to Italy 28 July 2023 7:05 pm July 28, 202311:27:53 am BOULDER — SomaLogic Inc. (Nasdaq: SLGC) is partnering with Dante Genomics, a European genomics and precision medicine company, to introduce SomaLogic’s proteomics technology to the Italian market. SomaLogic develops platforms to …
- SomaLogic partners with Dante Genomicsto offer comprehensive solution for proteomics testing in Europe 25 July 2023 10:51 am SomaLogic Operating Co. Inc., a leader in data-driven proteomics technology, announced its partnership with Dante Genomics, a global leader in genomics and precision medicine, to offer a comprehensive solution for proteomics testing at scale in Europe. …
- Dante Genomics to Offer SomaLogic Proteomics Testing to Researchers in Europe 24 July 2023 3:28 pm NEW YORK – SomaLogic and Italy's Dante Genomics said on Monday that they have partnered to offer services on SomaLogic's SomaScan proteomics platform to researchers in Europe. Under the terms of the partnership, Dante will run SomaScan, which can …
- SomaLogic partners with Dante Genomics to enhance clinical and research adoption of proteomics in Europe 24 July 2023 11:30 am BOULDER, Colo. and L’AQUILA, Italy, July 24, 2023 (GLOBE NEWSWIRE) — SomaLogic Operating Co. Inc., (Nasdaq:SLGC), a leader in data-driven proteomics technology, today announced its partnership with Dante Genomics, a global leader in genomics and precision …
- King's College Dubai leads UAE's battle against bowel cancer 23 June 2023 7:43 pm The British healthcare leader initiates a whole genome sequencing Study to improve colorectal cancer diagnosis and therapy for the Emirati population Published: Fri 23 Jun 2023, 5:31 PM Last updated: Fri 23 Jun 2023, 5:34 PM In a historic first for the UAE …
- Dante Genomics offers free, first-step feature of its AVANTI Software to turn FASTQ to VCF files on its platform agnostic genomic interpretation software 15 May 2023 4:52 pm – Initial feature at no-cost to enable broad scalability of interpretation software to benefit sequencing labs of all sizes around the world – NEW YORK, May 15, 2023 /PRNewswire/ — Dante Genomics, a global leader in genomics and precision …
- Dante Genomics receives grant for a whole genome sequencing project to measure utility of pharmacogenomics in a real, clinical setting 27 April 2023 8:17 pm – Highly coveted Innovation Grant by the Italian Government will measure impact of whole genome sequencing and pharmacogenomics starting from a specific population of cancer patients — NEW YORK, April 27, 2023 /PRNewswire/ — Dante Genomics, a …
- In Brief This Week: UC Berkeley, Biocept, Biocartis, Angle, Twist Bioscience, More 21 April 2023 3:18 pm NEW YORK – TED's Audacious Project said this week that it is providing $70 million in funding to a research initiative led by Jennifer Doudna and Jill Banfield at the Innovative Genomics Institute (IGI) at the University of California, Berkeley. The …
- Evo Pricing announces partnership with Dante Genomics to work toward a healthier future 19 April 2023 3:57 am London, United Kingdom , April 18, 2023 (GLOBE NEWSWIRE) — Evo Pricing is partnering with Dante Genomics to offer full DNA sequencing to employees in an effort to improve their well-being while further expanding the adoption of AI technology into the …
- Evo Pricing announces partnership with Dante Genomics to work toward a healthier future 19 April 2023 1:55 am London, United Kingdom , April 18, 2023 (GLOBE NEWSWIRE) — Evo Pricing is partnering with Dante Genomics to offer full DNA sequencing to employees in an effort to improve their well-being while further expanding the adoption of AI technology into the …
- New Products Posted to GenomeWeb: Stilla Technologies, Dante Genomics, Bio-Rad Laboratories, More 24 March 2023 8:35 pm Stilla Technologies Ruby Chip for Naica Digital PCR System Stilla Technologies has introduced the Ruby chip, a 'load-and-go' consumable for digital PCR that is optimized for the Naica system. The Ruby chip has adjustable throughput to process up to …
- Dante Genomics launches Avanti Software for a plug-and-play genomic interpretation that takes minutes instead of hours 20 March 2023 12:23 pm NEW YORK, March 20, 2023 /PRNewswire/ — Dante Genomics, a global leader in genomics and precision medicine, launched today the beta version of Avanti, the Company's proprietary B2B software for variant interpretation and report writing at …
- No. 1 in the Northeast: Maine startup business is region’s fastest-growing, says Inc. 7 March 2023 7:41 am A Portland startup ranks No. 1 on a prestigious list of fast-growing companies compiled by one of the country’s most widely read business publications, Inc. magazine. Rarebreed Veterinary Partners topped Inc.’s ranking of private companies in the Northeast …
- In Brief This Week: T2 Biosystems, Novacyt, OpGen, Dante Genomics, Nautilus Biotechnology, More 28 January 2023 2:21 am NEW YORK – T2 Biosystems announced preliminary financial results this week. For the recently completed fourth quarter, the firm had total revenue of $5.5 million, including product revenue of $2.2 million and research contribution revenue of $3.3 million. …
- Sequenzierzentrum von Dante Genomics in Dubai erhält Akkreditierung als medizinisches Labor nach ISO 15189 – Klinische Ganzgenomsequenzierung wird der nächsten Milliarde Patienten zugänglich gemacht 25 January 2023 9:58 pm NEW YORK, Jan. 25, 2023 (GLOBE NEWSWIRE) — Dante Genomics, ein weltweit führendes Unternehmen im Bereich Genomik und Präzisionsmedizin, hat heute bekanntgegeben, dass sein Labor in Dubai, das als globales Zentrum für die östliche Hemisphäre dient, die …
- El centro de secuenciación de Dante Genomics en Dubai recibe la acreditación de laboratorio médico ISO 15189 para ofrecer la secuenciación clínica del genoma completo a los próximos mil millones de pacientes 25 January 2023 9:58 pm NUEVA YORK, Jan. 25, 2023 (GLOBE NEWSWIRE) — Dante Genomics, líder mundial en genómica y medicina de precisión, ha anunciado hoy que su laboratorio de Dubai, que ejerce funciones de centro mundial para el hemisferio oriental, ha recibido la acreditación …
- L'hub di sequenziamento di Dante Genomics a Dubai riceve l'accreditamento di laboratorio medico ai sensi della norma ISO 15189 per aumentare il numero di pazienti sottoposti a sequenziamento clinico dell'intero genoma fino a raggiungere il miliardo… 25 January 2023 9:58 pm NEW YORK, Jan. 25, 2023 (GLOBE NEWSWIRE) — Dante Genomics, leader mondiale nella genomica e nella medicina di precisione, ha annunciato in data odierna che il suo laboratorio di Dubai, che funge da hub globale per l'emisfero orientale, ha ricevuto l…
- Le hub de séquençage de Dante Genomics à Dubaï reçoit l'accréditation de laboratoire médical ISO 15189 pour apporter le séquençage clinique du génome entier à un milliard de patients de plus 25 January 2023 9:58 pm NEW YORK, 25 janv. 2023 (GLOBE NEWSWIRE) — Dante Genomics, un leader mondial de la génomique et de la médecine de précision, a annoncé aujourd'hui que son laboratoire à Dubaï, qui joue le rôle de hub mondial pour l'hémisphère Est, a reçu l' …
- Sequencing hub van Dante Genomics in Dubai ontvangt ISO 15189 accreditatie voor medische laboratoria om klinische genoomsequentie aan de volgende miljard patiënten aan te bieden 25 January 2023 9:58 pm NEW YORK, Jan. 25, 2023 (GLOBE NEWSWIRE) — Dante Genomics, een wereldleider in genomica en precisiegeneeskunde, heeft vandaag aangekondigd dat hun laboratorium in Dubai, dat dient als wereldwijde hub voor het oostelijk halfrond, de medische …
- Dante Genomics’ sequencing hub in Dubai receives ISO 15189 Medical Laboratory accreditation to bring clinical whole genome sequencing to the next billion patients 25 January 2023 12:30 pm NEW YORK, Jan. 25, 2023 (GLOBE NEWSWIRE) — Dante Genomics, a global leader in genomics and precision medicine, announced today that their laboratory in Dubai, which serves as a global hub for the Eastern Hemisphere, has received Medical Laboratory …
- Dante Genomics participará en la 41ª edición de la J.P. Morgan Health Care Conference 4 January 2023 3:45 am NUEVA YORK, Jan. 04, 2023 (GLOBE NEWSWIRE) — Dante Genomics, líder mundial en genómica y medicina de precisión, se complace en anunciar que la empresa presentará una ponencia en la 41ª edición de la J.P. Morgan Health Care Conference que se celebrará en …
- Dante Genomics verzorgt presentatie op de 41e jaarlijkse J.P. Morgan Healthcare Conference 4 January 2023 3:45 am NEW YORK, Jan. 04, 2023 (GLOBE NEWSWIRE) — Dante Genomics, een wereldleider in genomica en precisiegeneeskunde, kondigt aan dat het volgende week een presentatie zal geven op de 41e jaarlijkse J.P. Morgan Healthcare Conference in San Francisco. Andrea …
- Presentazione di Dante Genomics in occasione della 41a J.P. Morgan Healthcare Conference annuale 4 January 2023 3:45 am NEW YORK, Jan. 04, 2023 (GLOBE NEWSWIRE) — Dante Genomics, leader globale nella genomica e nella medicina di precisione, è lieta di annunciare che la società sarà presente alla 41a J.P. Morgan Healthcare Conference annuale a San Francisco la prossima …
- Dante Genomics fera une présentation lors de la 41e conférence annuelle J.P. Morgan sur les soins de santé 4 January 2023 3:45 am NEW YORK, 04 janv. 2023 (GLOBE NEWSWIRE) — Dante Genomics, un leader mondial de la génomique et de la médecine de précision, a le plaisir d'annoncer que, la semaine prochaine, la société fera une présentation lors de la 41e conférence annuelle J.P. …
- Dante Genomics hält auf der 41. jährlichen J.P. Morgan Healthcare Conference einen Vortrag 4 January 2023 3:45 am NEW YORK, Jan. 04, 2023 (GLOBE NEWSWIRE) — Dante Genomics, ein weltweit führendes Unternehmen im Bereich der Genomik und Präzisionsmedizin, freut sich, bekanntzugeben, dass das Unternehmen nächste Woche auf der 41. jährlichen J.P. Morgan Healthcare …
- Dante Genomics to present at the 41st Annual J.P. Morgan Healthcare Conference 3 January 2023 12:30 pm NEW YORK, Jan. 03, 2023 (GLOBE NEWSWIRE) — Dante Genomics, a global leader in genomics and precision medicine, is pleased to announce that the Company will present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco next week. Andrea …
- Pakistan Inaugurates First Dante Genomics Lab In Islamabad 21 December 2022 7:28 am The minister stated that the establishment of Dante Lab in Islamabad, would allow the country to benefit from the most recent genomic technologies and research. The Federal Minister for Commerce inaugurated first “Dante Genomics Lab in Islamabad” on …
- Genomic Biopharma en patiëntenbelangenorganisatie POIC e dintorni APS werken samen om whole genome sequencing aan te bieden voor betere (curatieve) behandelingen voor patiënten met maag- en darmziekten 13 December 2022 3:44 pm L’AQUILA, Italië, Dec. 13, 2022 (GLOBE NEWSWIRE) — Genomic Biopharma Inc., een bedrijf dat geneesmiddelen op basis van genomische geneeskunde ontdekt en ontwikkelt, is een partnerschap aangegaan met de Associazione Poic e Dintorni APS (‘POIC e dintorni …
- Genomic Biopharma e l’organizzazione per la tutela dei pazienti POIC e dintorni APS collaborano al fine di offrire un sequenziamento dell'intero genoma che permetta di ottenere trattamenti e cure migliori per coloro che vivono con patologie… 13 December 2022 3:44 pm L’AQUILA, Italia, Dec. 13, 2022 (GLOBE NEWSWIRE) — Genomic Biopharma Inc., un'azienda dedicata alla scoperta e allo sviluppo di nuovi farmaci basati sulla medicina genomica, ha collaborato con l’Associazione POIC e Dintorni APS (“POIC e dintorni APS …
- Genomic Biopharma se asocia con la organización para la defensa del paciente POIC e dintorni APS para secuenciar el genoma completo y mejorar el tratamiento y la cura de las personas con enfermedades gastrointestinales crónicas 13 December 2022 3:44 pm L’AQUILA, Italia, Dec. 13, 2022 (GLOBE NEWSWIRE) — Genomic Biopharma Inc., una empresa que identifica y desarrolla fármacos basándose en la medicina genómica, se ha asociado con Associazione Poic e Dintorni APS («POIC e dintorni APS»), una organización …
- Genomic Biopharma et l'organisation de représentation des patients POIC e dintorni APS s'associent pour proposer le séquençage du génome entier afin d'apporter de meilleurs traitements et remèdes aux personnes atteintes de maladies… 13 December 2022 3:44 pm L'AQUILA, Italie, 13 déc. 2022 (GLOBE NEWSWIRE) — Genomic Biopharma Inc., une société de découverte et de développement de médicaments basés sur la médecine génomique, s'est associée avec Associazione Poic e Dintorni APS (« POIC e dintorni APS »), …
- Genomic Biopharma und die Patientenorganisation POIC e dintorni APS bieten gemeinsam die Sequenzierung des gesamten Genoms zur Ermöglichung besserer Behandlungen und Heilungsmöglichkeiten für Menschen mit Magen-Darm-Erkrankungen an 13 December 2022 3:44 pm L'AQUILA, Italien, Dec. 13, 2022 (GLOBE NEWSWIRE) — Genomic Biopharma Inc., ein Unternehmen für die auf genomischer Medizin basierende Erforschung und Entwicklung von Arzneimitteln, ist eine Partnerschaft mit der Associazione Poic e Dintorni APS („ …
- Genomic Biopharma and patient advocacy organization POIC e dintorni APS partner to offer whole genome sequencing to bring better treatments and cures to those living with gastrointestinal diseases 12 December 2022 12:30 pm L’AQUILA, Italy, Dec. 12, 2022 (GLOBE NEWSWIRE) — Genomic Biopharma Inc., a genomic medicine-based drug discovery and development company, has partnered with Associazione Poic e Dintorni APS (“POIC e dintorni APS”), a patient organization that supports …
- Dante Genomics lancia il sequenziamento clinico del genoma completo richiesto dal medico negli Stati Uniti in collaborazione con 1health.io 8 December 2022 9:52 am NEW YORK, Dec. 08, 2022 (GLOBE NEWSWIRE) — 1health.io Inc. (“1health”), società software leader del settore che consente ai laboratori di lanciare rapidamente nuovi prodotti di analisi nei mercati clinici e online, collabora con Dante Genomics, leader …
- Dante Genomics lance le séquençage clinique du génome entier sur ordonnance médicale aux États-Unis en partenariat avec 1health.io 8 December 2022 9:52 am NEW YORK, 08 déc. 2022 (GLOBE NEWSWIRE) — 1health.io Inc. (« 1health »), entreprise de premier plan dans le secteur des logiciels qui permet aux laboratoires de lancer rapidement de nouveaux produits de test sur les marchés cliniques et en ligne, s' …
- Dante Genomics lanza la secuenciación del genoma completo con fines clínicos por orden médica en los EE. UU. en colaboración con 1health.io 8 December 2022 9:52 am NUEVA YORK, Dec. 08, 2022 (GLOBE NEWSWIRE) — 1health.io Inc. (“1health”), una empresa de software líder en la industria que permite a los laboratorios lanzar nuevos productos de prueba rápidamente a los mercados clínicos y en línea, se asocia con Dante …
- Dante Genomics lanceert medische whole genome sequencing in de VS in samenwerking met 1health.io. 8 December 2022 9:52 am NEW YORK, Dec. 08, 2022 (GLOBE NEWSWIRE) — 1health.io Inc. (“1health”), een toonaangevend softwarebedrijf dat laboratoria in staat stelt nieuwe testproducten snel op de klinische en online markt te brengen, slaat de handen ineen met Dante Genomics, een …
- Dante Genomics führt in den USA in Zusammenarbeit mit 1health.io vom Arzt angeordnete, klinische Gesamtgenomsequenzierung ein 8 December 2022 9:52 am NEW YORK, New York (USA), Dec. 08, 2022 (GLOBE NEWSWIRE) — 1health.io Inc. („1health“), ein branchenführendes Softwareunternehmen, das Labore in die Lage versetzt, neue Testprodukte schnell auf den klinischen und Online-Markt zu bringen, arbeitet mit …
- Dante Genomics launches doctor ordered, clinical whole genome sequencing in the U.S. in partnership with 1health.io 7 December 2022 12:30 pm Dante Genomics uses 1health.io platform to accelerates their go to market and expand availability in all 50 states using the 1health online prescription service SAN FRANCISCO, CALIFORNIA, U.S.A, December 7, 2022 /EINPresswire.com/ — 1health.io …
- Dante Genomics launches doctor ordered, clinical whole genome sequencing in the U.S. in partnership with 1health.io 7 December 2022 12:30 pm NEW YORK, Dec. 07, 2022 (GLOBE NEWSWIRE) — 1health.io Inc. (“1health”), an industry-leading software company that empowers laboratories to launch new test products quickly into both clinical and online markets, partners with Dante Genomics, a global …
- Al Farabi Medical Laboratories und Dante Genomics kündigen globale Partnerschaft für die Bereitstellung von Next Generation Sequencing-Genomtests im Königreich Saudi-Arabien an 10 November 2022 3:16 pm NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) — Al Farabi Medical Laboratories, das führende medizinische Labor im Königreich Saudi-Arabien mit mehr als 50 Labors in allen Regionen des Königreichs, und Dante Genomics, ein weltweit führendes Unternehmen im …
- Al Farabi Medical Laboratories y Dante Genomics anuncian una colaboración a nivel mundial para el desarrollo de pruebas genómicas de secuenciación de nueva generación en el Reino de Arabia Saudí 10 November 2022 3:16 pm NUEVA YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) — Al Farabi Medical Laboratories, el laboratorio médico líder del Reino de Arabia Saudí que cuenta con más de 50 laboratorios en todas las regiones del Reino, y Dante Genomics, un líder mundial en genómica y …
- Al Farabi Medical Laboratories e Dante Genomics annunciano una partnership globale per la fornitura di test genomici di sequenziamento innovativi in Arabia Saudita 10 November 2022 3:16 pm NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) — Al Farabi Medical Laboratories, il più importante laboratorio medico in Arabia Saudita con oltre 50 centri distribuiti in tutte le regioni del Regno, e Dante Genomics, leader globale nella genomica e nella …
- Al Farabi Medical Laboratories et Dante Genomics annoncent un partenariat mondial pour la fourniture de tests génomiques de séquençage de nouvelle génération au Royaume d'Arabie saoudite 10 November 2022 3:16 pm NEW YORK, 10 nov. 2022 (GLOBE NEWSWIRE) — Al Farabi Medical Laboratories, les principaux laboratoires médicaux du Royaume d'Arabie saoudite avec plus de 50 laboratoires couvrant toutes les régions du Royaume, et Dante Genomics, un leader mondial de la …
- Al Farabi Medical Laboratories en Dante Genomics kondigt wereldwijde samenwerking aan voor de levering van Next Generation Sequencing Genomic Testing in het Koninkrijk Saudi-Arabië. 10 November 2022 3:16 pm NEW YORK, Nov. 10, 2022 (GLOBE NEWSWIRE) — Al Farabi Medical Laboratories, de toonaangevende medische laboratoria in het Koninkrijk Saoedi-Arabië met meer dan 50 laboratoria in alle regio's van het Koninkrijk, en Dante Genomics, een wereldleider op …
- Al Farabi Medical Laboratories and Dante Genomics announce global partnership for the delivery of Next Generation Sequencing Genomic Testing in the Kingdom of Saudi Arabia 9 November 2022 2:33 pm NEW YORK, Nov. 09, 2022 (GLOBE NEWSWIRE) — Al Farabi Medical Laboratories, the leading medical laboratories in the Kingdom of Saudi Arabia with more than 50 labs covering all regions of the Kingdom, and Dante Genomics, a global leader in genomics and …
- Al Farabi Medical Laboratories and Dante Genomics announce global partnership for the delivery of Next Generation Sequencing Genomic Testing in the Kingdom of Saudi Arabia 9 November 2022 12:30 pm NEW YORK, Nov. 09, 2022 (GLOBE NEWSWIRE) — Al Farabi Medical Laboratories, the leading medical laboratories in the Kingdom of Saudi Arabia with more than 50 labs covering all regions of the Kingdom, and Dante Genomics, a global leader in genomics and …
- Dante Genomics präsentiert auf dem Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum 8 November 2022 3:44 pm NEW YORK, Nov. 08, 2022 (GLOBE NEWSWIRE) — Dante Genomics, ein weltweit führendes Unternehmen im Bereich der Genomik und Präzisionsmedizin, hat bekanntgegeben, dass das Unternehmen am Canaccord Genuity MedTech, Diagnostics and Digital Health and Services …